Successful Treatment of Colombian Cutaneous Leishmaniasis with Four Injections of Pentamidine

Jaime Soto Bogota Military Hospital, Bogota, Colombia

Search for other papers by Jaime Soto in
Current site
Google Scholar
PubMed Close
,
Pierre Buffet Bogota Military Hospital, Bogota, Colombia

Search for other papers by Pierre Buffet in
Current site
Google Scholar
PubMed Close
,
Max Grogl Bogota Military Hospital, Bogota, Colombia

Search for other papers by Max Grogl in
Current site
Google Scholar
PubMed Close
, and
Jonathan Berman Bogota Military Hospital, Bogota, Colombia

Search for other papers by Jonathan Berman in
Current site
Google Scholar
PubMed Close
DOI:
https://doi.org/10.4269/ajtmh.1994.50.107
Volume/Issue:
Volume 50: Issue 1
Page(s):
107–111
Restricted access
Get Permissions

We previously found that 2 mg of pentamidine isethionate/kg, administered every other day in seven injections, was 95% curative for Colombian cutaneous leishmaniasis. However, 17% of the patients had to prematurely terminate therapy due to drug toxicity and another 30% had mild-to-moderate toxic clinical reactions. In this report, we show that the same daily dose of drug, 2 mg/kg, but administered in only four every-other-day injections, resulted in an 84% cure rate in 38 patients. Twenty-one patients (55%) experienced side effects, three of which were moderate to severe. A higher daily dose of drug, 3 mg/kg, administered in four every-other-day injections, resulted in a 96% cure rate in 51 evaluable patients. Thirty-six of the treated patients (64%) experienced side effects, five of which were moderate to severe. Although hypotension and hypoglycemia were looked for in all patients, only one patient experienced hypoglycemia and it had normalized by follow-up. We propose that the regimen of 3 mg of pentamidine/kg every other day in four injections is optimal for Colombian cutaneous leishmaniasis and competitive with standard Glucantime therapy, in terms of cure rate, toxicity, length of time the patient has to be under medical supervision, and cost of drug plus medical attention. We suggest that such a short course of injectable agent be studied for the treatment of patients with cutaneous leishmaniasis from other endemic areas.

Author Notes

Copyright:
Copyright © 1994 by The American Society of Tropical Medicine and Hygiene 1994
Published Online:
Jan 1994
Cover The American Journal of Tropical Medicine and Hygiene
The American Journal of Tropical Medicine and Hygiene
Print ISSN:
0002-9637
Past two years Past Year Past 30 Days
Abstract Views 1087 647 34
Full Text Views 22 6 0
PDF Downloads 26 10 0
 

 

 

 
 
Affiliate Membership Banner
 
 
Research for Health Information Banner
 
 
CLOCKSS
 
 
 
Society Publishers Coalition Banner
Save